Phreesia, Inc. (NYSE:PHR) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its stake in shares of Phreesia, Inc. (NYSE:PHR) by 10.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 493,448 shares of the company’s stock after acquiring an additional 46,209 shares during the period. Charles Schwab Investment Management Inc. owned about 0.85% of Phreesia worth $12,415,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. R Squared Ltd acquired a new position in shares of Phreesia during the 4th quarter worth about $30,000. BankPlus Trust Department acquired a new position in shares of Phreesia during the fourth quarter valued at approximately $34,000. Venturi Wealth Management LLC purchased a new position in shares of Phreesia in the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC boosted its stake in shares of Phreesia by 154.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company’s stock worth $89,000 after acquiring an additional 2,090 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of Phreesia during the third quarter worth approximately $247,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 1,311 shares of Phreesia stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71. Following the transaction, the senior vice president now owns 115,633 shares of the company’s stock, valued at $3,076,994.13. The trade was a 1.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Evan Roberts sold 2,873 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the transaction, the chief operating officer now directly owns 779,993 shares in the company, valued at approximately $20,755,613.73. This represents a 0.37 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 162,442 shares of company stock valued at $4,611,300. Corporate insiders own 5.80% of the company’s stock.

Analyst Ratings Changes

PHR has been the topic of a number of research reports. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Robert W. Baird decreased their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Piper Sandler reissued an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, KeyCorp boosted their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has an average rating of “Buy” and a consensus target price of $31.33.

Phreesia Price Performance

Shares of NYSE PHR opened at $27.45 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -18.68 and a beta of 1.03. The stock’s 50-day moving average is $27.33 and its two-hundred day moving average is $24.07. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.